Wikipedia:Articles for deletion/Bemarituzumab
I couldn't find any mention in PubMed, which is a red flag. However there are press releases available so I added one (Business Wire) to the article. I also added a short description from the National Cancer Institute. I looked for a specific drugs notability guideline in Wikipedia, at ,  and , but we don't seem to have one. In particular, I could find no mention of Phase II or III drugs being inherently notable. I am reluctant to delete because I think that bemarituzumab is likely to become notable in the next couple of years. Nevertheless, I acknowledge that the drug does not currently meet Wikipedia's general notability guideline standard
— User:Axl, 14:24, 17 November 2018 (UTC)
Stance: delete
Cited policy: WP:N||WP:SNG||WP:PHARM (Wikipedia:Notability)